A Retrospective Review of Supratherapeutic Modafinil Exposures

Journal of Medical Toxicology

Volumn 6, Issue 3, 2010, Pages 307-310

  Carstairs, Shaun D ^a   Urquhart, Andrew ^c   Hoffman, Justin ^c   Clark, Richard F ^a,b   Cantrell, F Lee ^b  

^a University of California   (United States)

^b California Poison Control System   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Modafinil; Overdose; Poisoning

Indexed keywords

ACTIVATED CARBON; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; INFUSION FLUID; MODAFINIL; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; AGED; AGITATION; ANXIETY; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIZZINESS; DRUG EXPOSURE; DRUG INTOXICATION; DYSKINESIA; DYSTONIA; ENVIRONMENTAL EXPOSURE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POISON CENTER; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; TACHYCARDIA; TREMOR; DRUG EFFECTS; DRUG OVERDOSE; INFANT; MIDDLE AGED; WAKEFULNESS;

ADOLESCENT; ADULT; AGED; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; OVERDOSE; RETROSPECTIVE STUDIES; WAKEFULNESS; DRUG OVERDOSE;

EID: 77956182985     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0017-6     Document Type: Article

References (23)

1. Lange R, Volkmer M, Heesen C, Liepert J (2009) Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 256: 645-650.
2. Ondo WG, Fayle R, Atassi F, Jankovic J (2005) Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 76: 1636-1639.
3. Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ (2004) Modafinil treatment for fatigue in HIV+ patients: a pilot study. J Clin Psychiatry 65: 1688-1695.
4. Blackhall L, Petroni G, Shu J, Baum L, Farace E (2009) A pilot study evaluating the safety and efficacy of modafinil for cancer-related fatigue. J Palliat Med 12: 433-439.
5. Pachas WN (2003) Modafinil for the treatment of fatigue of fibromyalgia. J Clin Rheumatol 9: 282-285.
6. Dackis C, O'Brien C (2003) Glutamatergic agents for cocaine dependence. Ann NY Acad Sci 1003: 328-345.
7. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30: 205-211.
8. Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW et al (2003) Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70: 29-37.
9. Saletu B, Saletu M, Grünberger J, Frey R, Zatschek I, Mader R (1990) On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies. Prog Neuropsychopharmacol Biol Psychiatry 14: 195-214.
10. Saletu B, Saletu M, Grünberger J, Frey R, Anderer P, Mader R (1993) Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. Neuropsychobiology 27: 26-39.
11. Menza MA, Kaufman KR, Castellanos A (2000) Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 61: 378-381.
12. Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33: 1477-1502.
13. Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L et al (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319: 561-569.
14. Simon P, Hémet C, Ramassamy C, Costentin J (1995) Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 5: 509-514.
15. De Séréville JE, Boer C, Rambert FA, Duteil J (1994) Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies. Neuropharmacology 33: 755-761.
16. Lackey GD, Alsop JA, Albertson TE (2007) A 24 month retrospective study of adult modafinil ingestions. Clin Toxicol (Phila) 45: 641 (abstract).
17. Lackey GD, Alsop JA, Sands TR, Albertson TE (2007) A two year retrospective study of pediatric modafinil ingestions. Clin Toxicol (Phila) 45: 643 (abstract).
18. Spiller HA, Borys D, Griffith JR, Klein-Schwartz W, Aleguas A, Sollee D et al (2009) Toxicity from modafinil ingestion. Clin Toxicol (Phila) 47: 153-156.
19. Physicians' Desk Reference (2003) Package insert for Provigil. Thomson PDR, Montvale, NJ.
20. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE et al (2008) 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th annual report. Clin Toxicol (Phila) 46: 927-1057.
21. Myrick H, Malcolm R, Taylor B, LaRowe S (2004) Modafinil: preclinical, clinical, and post-marketing surveillance-a review of abuse liability issues. Ann Clin Psychiatry 16: 101-109.
22. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F et al (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301: 1148-1154.
23. Erowid. org. Erowid vault: modafinil (cited 2009 Jun 2). Available from: http://www. erowid. org/smarts/modafinil/modafinil. shtml.